🔎 Trials Near Me

Home › Overweight › Ohio › Dayton

Overweight clinical trials in Dayton, OH

6 studies for Overweight are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

RecruitingPhase 3
  • PriMed Clinical Research, Dayton
Ages 8 to 18 · All sexes · Updated Sep 30, 2026 · NCT07253285

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 3
  • AURORA-1 Clinical Site, Dayton
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingPhase 3
  • AURORA-2 Clinical Site, Dayton
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RecruitingPhase 2
  • Providence Health Partners-Center for Clinical Research, Dayton
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RecruitingPhase 3
  • Hometown Urgent Care and Research - Dayton, Dayton
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351045

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RecruitingPhase 2
  • PriMED Clinical Research, Dayton
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07215559

Overweight trials in other cities

Other studies in Dayton

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.